San Diego-dependent Viking Therapeutics marked itself as a significant competitor in the weight loss drug sector in February following revealing promising info from a mid-stage trial of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when offered as being a weekly injection As well as in March the compan… Read More